Synthesis strategies and anti-parasitic evaluation of novel compounds for chagas disease: Advancing drug discovery through structure-activity relationships
European Journal of Medicinal Chemistry · 2025
DOI: 10.1016/j.ejmech.2024.117203 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Medicinal Chemistry, 2025. Verfasst von Jitendra Chaudhary und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India. Hauptthemen laut MEDLINE: Chagas Disease, Trypanosoma cruzi, Drug Discovery, Trypanocidal Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 123 Literaturangaben.
Abstract (Originalsprache)
This study presents a comprehensive exploration of the synthesis of novel compounds targeting Chagas Disease (CD) caused by Trypanosoma cruzi. It is a global health threat with over 6-7 million infections worldwide. Addressing challenges in current treatments, the investigation explores diverse compound classes, including thiazoles, thiazolidinone, imidazole, pyrazole, 1,6-diphenyl-1H-pyrazolo[3,4-b] pyridine, pyrrole, naphthoquinone, neolignan, benzeneacyl hydrazones, and chalcones-based compounds. Highlighting compounds with superior trypanocidal activity compared to standard drugs. The study elucidates structure-activity relationships, emphasizing the impact of substituents, fluorine presence, and substitution patterns. Noteworthy findings include neolignan derivatives demonstrating efficacy against intracellular amastigotes and free-moving trypomastigotes, with unsaturated side chains. Benzeneacylhydrazones and chalcones, as novel classes, showed varied efficacy, with certain compounds surpassing benznidazole. A novel series of triketone compounds exhibited strong anti-parasitic activity, outperforming standard drugs. Docking study revealed that the halogen and methoxy substituted phenyl ring, thiazole, thiazolidine-4-one, quinoline, isoindoline-1,3-dione, pyrrole heterocyclic motifs can play the key role in the designing of effective inhibitors of T. cruzi. Mutually, these insights placed the foundation for the development of innovative and effective treatments for CD, addressing the urgent need for improved therapeutic options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India.
- School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara, 144411, India.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, India. Electronic address: brar.iqubal@gmail.com.
Zitieren
APA
Chaudhary, J., Kaur, G., & Singh, I. (2025). Synthesis strategies and anti-parasitic evaluation of novel compounds for chagas disease: Advancing drug discovery through structure-activity relationships. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2024.117203
Vancouver
Chaudhary J, Kaur G, Singh I. Synthesis strategies and anti-parasitic evaluation of novel compounds for chagas disease: Advancing drug discovery through structure-activity relationships. European Journal of Medicinal Chemistry. 2025. doi:10.1016/j.ejmech.2024.117203
BibTeX
@article{Chaudhary2025,
author = {Chaudhary, Jitendra and Kaur, Gurdeep and Singh, Iqubal},
title = {Synthesis strategies and anti-parasitic evaluation of novel compounds for chagas disease: Advancing drug discovery through structure-activity relationships},
journal = {European Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1016/j.ejmech.2024.117203}
}
EUVIMED